New cell study examines how flavoured e-cigarette aerosol may affect lung repair cells

A new paper in the American Journal of Respiratory Cell and Molecular Biology reports laboratory evidence that a cinnamon-roll flavoured nicotine e-cigarette aerosol can disturb mitochondrial function in human alveolar type II cells, a cell type involved in maintaining and repairing the lung lining.

The study, published on 25 September 2026, used plasma from e-cigarette users, human primary alveolar cells, precision-cut lung slices from organ donors and mouse experiments. The authors reported signs of mitochondrial DNA damage, lipid peroxidation, changes in respiratory-chain proteins and molecular markers linked with ferroptosis, a form of regulated cell death.

For adult UK readers, the important point is scale. This is mechanistic laboratory evidence, not a study showing that a particular legal vape product causes a defined illness in people. It focuses on one flavoured aerosol with nicotine and on biological pathways that may help researchers understand possible lung injury mechanisms. It should not be read as a comparison between vaping and smoking, nor as evidence that all products or flavours behave identically.

How it fits with UK advice

The NHS continues to frame nicotine vaping as less harmful than smoking and as a tool some adult smokers use to stop smoking, while also making clear that vaping is not harmless and that non-smokers and children should not vape. The 2022 evidence review commissioned by the Office for Health Improvement and Disparities similarly described vaping as a small fraction of the risks of smoking in the short and medium term, while stressing that long-term evidence is still developing.

This new paper is useful because it adds detail to one possible biological pathway, not because it settles the public-health question on its own. For adults who smoke, the practical balance remains different from that for people who do not smoke: switching completely away from combustible tobacco reduces exposure to tar, carbon monoxide and many toxic products of combustion, but continuing to inhale aerosol is not risk-free.

What to watch next

The most useful follow-up evidence would include replicated studies across more e-liquid types, realistic exposure patterns, and clinical or population data that can connect laboratory changes with actual health outcomes. Until then, the study is best treated as a signal for further research and as a reminder that vaping should be limited to adults who are using it as an alternative to smoking.